Endovascular Treatment of Acute Stroke for Late arrivals.
This website provides information about the MR CLEAN LATE trial, a multicenter randomized clinical performed within the CONTRAST consortium. The goal is to assess the effect of endovascular treatment, compared with best medical treatment, in patients with acute ischemic stroke presenting between 6 and 24 hours after onset (or last seen well) caused by an intracranial large vessel occlusion of the anterior circulation.
In the menu on the left side of this website you will find links to the patient information forms (PIF), the case report form (CRF) and to the randomization site.
MR CLEAN LATE principal investigators on behalf of the CONTRAST consortium.
Robert van Oostenbrugge and Wim van Zwam
Maastricht University Medical Center, Maastricht